A Randomized Clinical Trial of CCX168, an Orally Administered C5aR Inhibitor for Treatment of Patients with ANCA-Associated VasculitisPeter A. Merkel,John Niles,Richard Jimenez,Robert F. Spiera,Brad H. Rovin,Andrew Bomback,Christian Pagnoux,Antonia Potarca,Thomas J. Schall,Pirow BekkerARTHRITIS & RHEUMATOLOGY(2016)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要